MedPath

Reducing Readmission for Frail Elderly Patients With Decompensated Heart Failure

Not Applicable
Completed
Conditions
Heart Failure
Acute Decompensated Heart Failure
Emergencies
Fragility
Interventions
Other: Control Group (Standard Care)
Behavioral: Intervention Group
Registration Number
NCT03246035
Lead Sponsor
Jewish General Hospital
Brief Summary

A randomized study designed to determine whether telephone based interventions can prevent return hospital visits for elderly and frail patients with acute symptoms of heart failure. Specifically, the intervention will improve patients ability to monitor and address self care of heart failure at home.

Detailed Description

Acute decompensated heart failure (ADHF) is a common illness in Canadian emergency departments (ED). The frail subset of elderly patients with ADHF is challenging to treat, use a large proportion of available resources, and are at higher risk for complications, including readmission to hospital after discharge. The investigators believe that by improving access to follow-up, optimizing self-care, and addressing the various cognitive and physical limitations of frailty, it will be possible to improve quality of life and reduce readmission rates for frail patients with ADHF.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Patients who presented to the ED and who are being discharged with a primary or secondary diagnosis of ADHF
  • Age ≥ 65
  • Frailty, defined as a FRAIL score >=3/5 or Clinical Frailty Scale (CFS) score >=5/9
  • Informed consent provided by the patient or proxy
Exclusion Criteria
  • Significant dementia or active delirium
  • Severe frailty, defined as a CFS score >=8/9
  • Prohibitive language barrier
  • Primary address outside of Quebec
  • Patient deemed to be palliative or moribund by treating team

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control Group (Standard Care)Control Group (Standard Care)The control group will receive outpatient follow-up, medication advice and lifestyle guidance as prescribed at discharge from the ED or hospital.
Intervention GroupIntervention GroupThe intervention will consist of contacting the patient 5 days post-discharge and arranging definitive outpatient follow-up and providing targeted medical and lifestyle advice based on deficient domains identified at baseline.
Primary Outcome Measures
NameTimeMethod
All-cause death, hospital readmission, or ED revisit90 days
Secondary Outcome Measures
NameTimeMethod
Frailty Index90 days

Change in the Frailty Index from enrollment to follow-up

Informed consent validation (qualitative)90 days

Qualitative feedback from participants regarding the informed consent process

Self-Care Index90 days

Change in the Self-Care Heart Failure Index from enrollment to follow-up

Rate of return visits to any ER for any medical issue30 days

Number of times enrolled patient visits an emergency department for any medical issue, over the 90 day follow-up period.

Rate of admission to hospital at 90 days90 days

Number of times the patient needs to be admitted to hospital for any medical issue, over the 3 month follow-up period.

Heart Failure Symptom Scale90 days

Change in the 12 point Heart Failure Symptom Scale from enrollment to follow-up

Incidence of adverse effects from medication90 days

Number of patients who experience unexpected side effects from their heart failure medications

Recruitment rate90 days

The number of eligible of patients recruited into the study over a 3 month trial period

Attrition rate90 days

The number of patients enrolled the study who choose to leave the study before completing the follow-up

All-cause death, hospital readmission, or ED revisit1 year

Trial Locations

Locations (1)

Jewish General Hospital

🇨🇦

Montréal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath